Left main disease
Known hypersensitivity or contraindication to any of the following medications: Heparin, aspirin, clopidogrel, sirolimus, siptagliptin and statin
Congestive heart failure (patients with LVEF <30% or cardiogenic shock)
Uncontrolled myocardial ischemia (repeated chest pain or dyspnea after revascularization)
Uncontrolled ventricular arrhythmia
History of malignancy with chemotherapy
Serious hematologic disease (e.g. CML, MDS)
Current infectious disease needs antibiotics therapy
Creatinine level >1.5 mg/dL or dependence on dialysis
Other severe concurrent illness (e.g. active infection, malignancy).
Life expectancy of less than one year
Pregnancy or women with potential childbearing
Type I DM
Treatment with insulin
History of pancreatitis
Who cannot read the informed consent form (e.g. illiteracy, foreigner)

NCT02802644_exc_T1
Condition
Left main disease
NCT02802644_exc_T2
Condition
hypersensitivity
NCT02802644_exc_T3
Condition
contraindication
NCT02802644_exc_T4
Drug
Heparin
NCT02802644_exc_T5
Drug
aspirin
NCT02802644_exc_T6
Drug
clopidogrel
NCT02802644_exc_T7
Drug
sirolimus
NCT02802644_exc_T8
Drug
siptagliptin
NCT02802644_exc_T9
Drug
statin
NCT02802644_exc_T10
Scope
Heparin, aspirin, clopidogrel, sirolimus, siptagliptin and statin
NCT02802644_exc_T11
Scope
hypersensitivity or contraindication
NCT02802644_exc_T12
Condition
Congestive heart failure
NCT02802644_exc_T13
Measurement
LVEF
NCT02802644_exc_T14
Value
<30%
NCT02802644_exc_T15
Condition
cardiogenic shock
NCT02802644_exc_T16
Scope
VEF <30% or cardiogenic shock
NCT02802644_exc_T17
Condition
myocardial ischemia
NCT02802644_exc_T18
Qualifier
Uncontrolled
NCT02802644_exc_T19
Condition
chest pain
NCT02802644_exc_T20
Qualifier
repeated
NCT02802644_exc_T21
Condition
dyspnea
NCT02802644_exc_T22
Temporal
after revascularization
NCT02802644_exc_T23
Reference_point
revascularization
NCT02802644_exc_T24
Procedure
revascularization
NCT02802644_exc_T25
Scope
chest pain or dyspnea
NCT02802644_exc_T26
Condition
ventricular arrhythmia
NCT02802644_exc_T27
Qualifier
Uncontrolled
NCT02802644_exc_T28
Condition
malignancy
NCT02802644_exc_T29
Procedure
chemotherapy
NCT02802644_exc_T30
Condition
hematologic disease
NCT02802644_exc_T31
Qualifier
Serious
NCT02802644_exc_T32
Condition
CML
NCT02802644_exc_T33
Condition
MDS
NCT02802644_exc_T34
Scope
CML, MDS
NCT02802644_exc_T35
Condition
infectious disease
NCT02802644_exc_T36
Drug
antibiotics
NCT02802644_exc_T37
Measurement
Creatinine level
NCT02802644_exc_T38
Value
>1.5 mg/dL
NCT02802644_exc_T39
Procedure
dialysis
NCT02802644_exc_T40
Condition
active infection
NCT02802644_exc_T41
Condition
malignancy
NCT02802644_exc_T42
Condition
illness
NCT02802644_exc_T43
Qualifier
concurrent
NCT02802644_exc_T44
Qualifier
severe
NCT02802644_exc_T45
Scope
active infection, malignancy
NCT02802644_exc_T46
Observation
ife expectancy
NCT02802644_exc_T47
Value
less than one year
NCT02802644_exc_T49
Condition
Type I DM
NCT02802644_exc_T50
Drug
insulin
NCT02802644_exc_T51
Condition
pancreatitis